189 related articles for article (PubMed ID: 27379732)
1. Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.
Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
Cancer; 2016 Oct; 122(20):3199-3206. PubMed ID: 27379732
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Lu-Yao GL; Albertsen PC; Moore DF; Lin Y; DiPaola RS; Yao SL
Eur Urol; 2015 Nov; 68(5):805-11. PubMed ID: 25800944
[TBL] [Abstract][Full Text] [Related]
3. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
5. Change in Functional Status After Prostate Cancer Treatment Among Medicare Advantage Beneficiaries.
Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
Urology; 2019 Sep; 131():104-111. PubMed ID: 31181274
[TBL] [Abstract][Full Text] [Related]
6. Physician visits prior to treatment for clinically localized prostate cancer.
Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
[TBL] [Abstract][Full Text] [Related]
7. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
8. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
Muralidhar V; Rose BS; Chen YW; Nezolosky MD; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):313-317. PubMed ID: 27496390
[TBL] [Abstract][Full Text] [Related]
9. Population-based assessment of determining predictors for quality of prostate cancer surveillance.
Chamie K; Williams SB; Hershman DL; Wright JD; Nguyen PL; Hu JC
Cancer; 2015 Dec; 121(23):4150-7. PubMed ID: 26307939
[TBL] [Abstract][Full Text] [Related]
10. Preliminary treatment considerations among men with newly diagnosed prostate cancer.
Zeliadt SB; Moinpour CM; Blough DK; Penson DF; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
Am J Manag Care; 2010 May; 16(5):e121-30. PubMed ID: 20455638
[TBL] [Abstract][Full Text] [Related]
11. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
12. Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013.
Fried DA; Sadeghi-Nejad H; Gu D; Zhou S; He W; Giordano SH; Pentakota SR; Demissie K; Helmer D; Shen C
Cancer Med; 2019 May; 8(5):2612-2622. PubMed ID: 30945473
[TBL] [Abstract][Full Text] [Related]
13. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis.
Zabell JR; Adejoro O; Jarosek SL; Elliott SP; Konety BR
World J Urol; 2016 Oct; 34(10):1397-403. PubMed ID: 26914817
[TBL] [Abstract][Full Text] [Related]
14. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.
Filson CP; Schroeck FR; Ye Z; Wei JT; Hollenbeck BK; Miller DC
J Urol; 2014 Jul; 192(1):75-80. PubMed ID: 24518783
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early-stage prostate cancer among rural and urban patients.
Baldwin LM; Andrilla CH; Porter MP; Rosenblatt RA; Patel S; Doescher MP
Cancer; 2013 Aug; 119(16):3067-75. PubMed ID: 23765584
[TBL] [Abstract][Full Text] [Related]
16. Factors that determine the treatment for local and regional prostate cancer.
Desch CE; Penberthy L; Newschaffer CJ; Hillner BE; Whittemore M; McClish D; Smith TJ; Retchin SM
Med Care; 1996 Feb; 34(2):152-62. PubMed ID: 8632689
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC
Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112
[TBL] [Abstract][Full Text] [Related]
19. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.
Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Lago-Hernandez C; Chen YW; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Trinh QD; Nguyen PL
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):273-9. PubMed ID: 24980272
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer.
Quek RG; Master VA; Ward KC; Lin CC; Virgo KS; Portier KM; Lipscomb J
Cancer; 2013 Oct; 119(20):3619-28. PubMed ID: 23913478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
